Lewis Darwin purchased $6K of LFVN
Lewis Darwin purchased 976 shares of Lifevantage Corp (LFVN) at $6.22 on 2026-09-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed purchase is modest and unlikely to affect market perception or stock price.
Market read
Low relevance; the filing provides a new but trivial data point.
What to watch
Potential upcoming corporate actions not disclosed could motivate insider buying.
Background
Form 4 filing reports insider transactions; Lifevantage Corp (LFVN) is a US-listed nutraceutical company.
Ticker impact
Director Lewis Darwin bought 976 shares for $6,070.72 via a 10b5-1 plan, increasing his stake to 138,244 shares.
No significant price change expected.
Purchase size is trivial relative to market cap and typical trading volume.
Market effects
None; insider activity does not affect sector trends.
None; limited to Lifevantage shareholders.
None
Counterpoint
Even small insider buys can signal confidence; monitor for future purchases.
Key entities
- companyLifevantage Corp
US-listed nutraceutical firm (ticker LFVN).
- personLewis Darwin
Director of Lifevantage Corp.